Markets:

Overview

News

Currencies

International

Treasuries

Awakn Life Sciences Corp (OP:AWKNF)

0.0650 UNCHANGED

Last Price Updated: 3:11 PM EST, Dec 13, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Awakn Life Sciences Corp

< Previous 1 2 3 4 5 Next >

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation ↗

October 18, 2021

The Week In Psychedelics

Via Benzinga

Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study ↗

September 27, 2021

The Week In Psychedelics:

Via Benzinga

Is Ketamine A Psychedelic? Depends On Who You Ask ↗

September 22, 2021

Ketamine, an FDA-approved anesthetic drug, has recently become the star of the psychedelic medicine movement. As p...

Via Benzinga

There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are ↗

October 13, 2021

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...

Via Benzinga

Cannabis Drug Stocks Have Mirrored Performance Of Psychedelic Drug Stocks To Date In September ↗

September 20, 2021

Which index has outperformed so far in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?

Via Talk Markets

Topics Cannabis

Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial ↗

September 20, 2021

AdvisorShares Launches First NYSE-listed Actively-managed Psychedelics ETF On Thursday, AdvisorShares

Via Benzinga

Cannabis And Psychedelic Drug Stock Performances Were Mixed Last Week ↗

September 11, 2021

The performance of the psychedelic-focused index components substantially outshone the weed stocks.

Via Talk Markets

Topics Cannabis

Marijuana Vs. Psychedelic Drug Stocks: Which Out-Performed Last Week? ↗

September 06, 2021

The Marijuana & Psychedelic Compounds-Based Drug Stocks Index consists of 8 constituents in each of two sub-categories, let's see which out-performed last week.

Via Talk Markets

Topics Cannabis

Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold ↗

August 30, 2021

Contents

Via Benzinga

Can Ketamine Be Used To Treat Gambling Addiction? Awakn Life Sciences Wants To Find Out ↗

August 24, 2021

Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB:AWKNF), a bio...

Via Benzinga

Psyched: Atai Launches 'Salvia Divinorum' Subsidiary, Mindset, Psilera and Wesana's Preclinical Trials, Origin Raises $5M ↗

August 16, 2021

Atai Life Sciences Launches New Salvia Divinorum Subsidiary Atai Life Sciences (NASDAQ:

Via Benzinga

Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected ↗

August 02, 2021

Last week in Psychedelics:

Via Benzinga

UK Psychedelics Co. Awakn Life Sciences Begins Listing On OTC Markets ↗

July 26, 2021

Awakn Life Sciences Corp. (NEO: AWKN) (OTC:AWKNF), a biotech...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.